<unk>  is part of personalized medicine as it describes the guiding principles for the discovery of pharmacogenomic biomarker tests, also referred to as companion diagnostic tests, which identify if an individual patient is likely to suffer severe drug toxicity from treatment with a specific therapeutic agent. Once at-risk individuals are identified, drug toxicity can be prevented using elective dose reduction or prescription of a different medication.
Toxgnostics
Veterinary parasitology
Cytotechnology
PathCheck
Venereology
Cancer staging
Forensic toxicology
Biochemistry